192 related articles for article (PubMed ID: 171277)
1. A testosterone-secreting, gonadotropin-responsive pure thecoma and polycystic ovarian disease.
Givens JR; Andersen RN; Wiser WL; Donelson AJ; Coleman SA
J Clin Endocrinol Metab; 1975 Nov; 41(5):845-53. PubMed ID: 171277
[TBL] [Abstract][Full Text] [Related]
2. The effects of continuous androgen secretion on the hypothalamic-pituitary axis in woman: evidence from a luteinized thecoma of the ovary.
Dunaif A; Scully RE; Andersen RN; Chapin DS; Crowley WF
J Clin Endocrinol Metab; 1984 Sep; 59(3):389-93. PubMed ID: 6086692
[TBL] [Abstract][Full Text] [Related]
3. Endometrial cancer associated with feminizing ovarian tumor and polycystic ovarian disease.
McDonald TW; Malkasian GD; Gaffey TA
Obstet Gynecol; 1977 Jun; 49(6):654-8. PubMed ID: 194178
[TBL] [Abstract][Full Text] [Related]
4. Ovarian steroid cell tumor and a contralateral ovarian thecoma in a postmenopausal woman with severe hyperandrogenism.
Cserepes E; Szücs N; Patkós P; Csapó Z; Molnár F; Tóth M; Dabasi G; Esik O; Rácz K
Gynecol Endocrinol; 2002 Jun; 16(3):213-6. PubMed ID: 12192893
[TBL] [Abstract][Full Text] [Related]
5. In vivo steroid studies in luteoma of pregnancy.
Nagamani M; Gomez LG; Garza J
Obstet Gynecol; 1982 Jun; 59(6 Suppl):105S-11S. PubMed ID: 6283444
[TBL] [Abstract][Full Text] [Related]
6. [Virilizing luteoma of pregnancy. Relation to polycystic ovaries].
Guilmot JL; Avignon JP; Lecomte P; Boscq G; Billard JJ; Delsol M
Sem Hop; 1983 Dec; 59(44):3053-7. PubMed ID: 6320393
[TBL] [Abstract][Full Text] [Related]
7. Ovarian thecoma with androgenic manifestations in a postmenopausal woman.
Siekierska-Hellmann M; Sworczak K; Babińska A; Wojtylak S
Gynecol Endocrinol; 2006 Jul; 22(7):405-8. PubMed ID: 16864153
[TBL] [Abstract][Full Text] [Related]
8. Isolated luteinizing hormone (LH) elevation in a woman with secondary amenorrhea: a clue to the diagnosis of an inhibin B-producing thecoma and insights into the influence of inhibin B on LH.
Donovan LE; Brain PH; Duggan MA
Fertil Steril; 2010 Aug; 94(3):1097.e9-1097.e12. PubMed ID: 20334861
[TBL] [Abstract][Full Text] [Related]
9. Testosterone-producing thecoma in a female cat.
Cellio LM; Degner DA
J Am Anim Hosp Assoc; 2000; 36(4):323-5. PubMed ID: 10914531
[TBL] [Abstract][Full Text] [Related]
10. Recurrent endometrial hyperplasia as a presentation of estrogen-secreting thecoma - case report and minireview of the literature.
Podfigurna-Stopa A; Czyzyk A; Katulski K; Moszynski R; Sajdak S; Genazzani AR; Meczekalski B
Gynecol Endocrinol; 2016; 32(3):184-7. PubMed ID: 26585670
[TBL] [Abstract][Full Text] [Related]
11. [Endocrinological study of Sertoli-Leydig cell tumor].
Haruyama Y; Miyakawa I; Inoue H; Mori N
Nihon Sanka Fujinka Gakkai Zasshi; 1987 May; 39(5):765-70. PubMed ID: 2955060
[TBL] [Abstract][Full Text] [Related]
12. Remission of acanthosis nigricans associated with polycystic ovarian disease and a stromal luteoma.
Givens JR; Kerber IJ; Wiser WL; Andersen RN; Coleman SA; Fish SA
J Clin Endocrinol Metab; 1974 Mar; 38(3):347-55. PubMed ID: 4360917
[No Abstract] [Full Text] [Related]
13. Ovarian 17-ketosteroid reductase deficiency as a possible cause of polycystic ovarian disease.
Toscano V; Balducci R; Bianchi P; Mangiantini A; Sciarra F
J Clin Endocrinol Metab; 1990 Aug; 71(2):288-92. PubMed ID: 2166066
[TBL] [Abstract][Full Text] [Related]
14. [Androgenic alopecia revealing an androgen secreting ovarian tumor].
Roux-Guinot S; Gorin I; Vadrot D; Djid R; Bethoux JP; Escande JP
Ann Dermatol Venereol; 2001 Nov; 128(11):1241-4. PubMed ID: 11908171
[TBL] [Abstract][Full Text] [Related]
15. The effects of ovarian wedge resection on circulating gonadotropin and ovarian steroid levels in patients with polycystic ovary syndrome.
Judd HL; Rigg LA; Anderson DC; Yen SS
J Clin Endocrinol Metab; 1976 Aug; 43(2):347-55. PubMed ID: 950366
[TBL] [Abstract][Full Text] [Related]
16. Intraoperative testosterone assay for virilizing ovarian tumor topographic assessment: report of a Leydig cell tumor of the ovary in a premenopausal woman with an adrenal incidentaloma.
Regnier C; Bennet A; Malet D; Guez T; Plantavid M; Rochaix P; Monrozies X; Louvet JP; Caron P
J Clin Endocrinol Metab; 2002 Jul; 87(7):3074-7. PubMed ID: 12107203
[TBL] [Abstract][Full Text] [Related]
17. Dynamics of plasma gonadotropin and sex steroid release in polycystic ovarian disease after pituitary-ovarian inhibition with an analog of gonadotropin-releasing hormone.
Calogero AE; Macchi M; Montanini V; Mongioi A; Maugeri G; Vicari E; Coniglione F; Sipione C; D'Agata R
J Clin Endocrinol Metab; 1987 May; 64(5):980-5. PubMed ID: 3104389
[TBL] [Abstract][Full Text] [Related]
18. The effects of long term testosterone administration on pulsatile luteinizing hormone secretion and on ovarian histology in eugonadal female to male transsexual subjects.
Spinder T; Spijkstra JJ; van den Tweel JG; Burger CW; van Kessel H; Hompes PG; Gooren LJ
J Clin Endocrinol Metab; 1989 Jul; 69(1):151-7. PubMed ID: 2471710
[TBL] [Abstract][Full Text] [Related]
19. Endocrine profile of an ovarian androblastoma.
Munemura M; Nakamura T; Matsuura K; Maeyama M; Iwamasa T
Obstet Gynecol; 1982 Jun; 59(6 Suppl):100S-4S. PubMed ID: 6283443
[TBL] [Abstract][Full Text] [Related]
20. Lipid cell tumor of the ovary in reference to adult-onset congenital adrenal hyperplasia and polycystic ovary syndrome. A case report.
Rosenfield RL; Cohen RM; Talerman A
J Reprod Med; 1987 May; 32(5):363-9. PubMed ID: 3598985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
